For complex disorders, variants in genes with clear biological and clinical importance, such as LDLRAP1, SCARB1, and NPC1L1 have been identified, corresponding to approximately 25% - 30% of the genetic variance for various dyslipidemia traits [48]. The gene discussed is NPC1L1; the disease is metabolic syndrome.